Automating Urology SMART on FHIR Prior Auth Workflows

The Imperative for Streamlined Urology Prior Authorization

Urology, with its blend of medical and surgical interventions, presents unique prior authorization challenges. High-cost specialty drugs for prostate cancer, minimally invasive BPH treatments, and advanced imaging require meticulous documentation and often trigger complex PA requirements. The urgency of cancer care initiation further amplifies the need for efficient, in-EMR PA processes.

High-Volume Urology PA Triggers

• Prostate cancer treatments: Androgen deprivation therapy (Lupron, Zoladex), oral androgen-receptor inhibitors (Xtandi, Zytiga), PSMA-targeted radiopharmaceuticals (Pluvicto).
• BPH treatments: Minimally invasive procedures like UroLift, Rezum, Aquablation, and traditional surgical interventions.
• Overactive bladder (OAB) treatments: Mirabegron/Myrbetriq, onabotulinumtoxinA/Botox injections, sacral neuromodulation (InterStim).
• Robotic urologic surgery: Prostatectomy, partial/radical nephrectomy, cystectomy.
• Advanced imaging: Multiparametric prostate MRI, PSMA PET imaging (Gallium-68 PSMA, Pylarify/F-18-DCFPyL) for staging and recurrence.

Elevating Efficiency with Urology SMART on FHIR Prior Auth

SMART on FHIR prior authorization transforms the PA workflow by embedding it directly within the EMR. For urology, this means clinicians and PA coordinators can initiate and manage requests for complex drugs and procedures without leaving Epic Hyperspace, Cerner PowerChart, athenaOne, or MEDITECH Expanse. This eliminates manual context transfer, reducing transcription errors and the cognitive load associated with switching between multiple applications.

Key Benefits of In-EMR Prior Auth for Urology

• **Reduced Context-Switching:** Clinicians remain in their native EMR environment, launching Klivira via SMART App Launch with patient and encounter context automatically transferred.
• **Automated Documentation Retrieval:** FHIR R4 reads US Core resources directly from the EMR, populating PA forms with necessary clinical data like Gleason score, PSA, IPSS, and prior medical therapy trials.
• **Structured Outcome Write-Back:** PA decisions are written back to the EMR as structured DocumentReference, Communication, or Task resources, ensuring consistent and queryable status updates.
• **Da Vinci PAS Alignment:** Supports industry standards like Da Vinci CRD for coverage requirements discovery and Da Vinci PAS for electronic submission, streamlining payer interactions for urology-specific services.

Klivira's Specialized Approach for Urology PA

Klivira's platform provides a robust solution for urology SMART on FHIR prior auth. Our system incorporates AUA Clinical Practice Guidelines and NCCN guidelines for urologic oncology, ensuring policy logic aligns with clinical evidence. We automate the documentation of prostate cancer regimens, BPH conservative-therapy trials, and ED/OAB benefit coverage routing, adapting to the specific requirements of major payers and EMR systems.

Addressing Common Urology PA Denials

• **Step Therapy:** Automated checks for required step therapy trials for ED treatments and OAB medications.
• **Medical-Necessity Gaps:** Proactive identification of missing documentation, such as Gleason score, stage, or PSA, for advanced prostate cancer drugs.
• **NCD/LCD Constraints:** Guidance on specific CMS National/Local Coverage Determinations applicable to services like PSMA imaging.
• **Insufficient Conservative Therapy:** Flagging and assisting with documentation for required durations of conservative therapy for BPH and OAB treatments.